Director Value, Access and Policy, region Europe @ Amgen (Europe GmbH) (June 2014 - December 2016)
Global Market Access Assoc. Director @ (October 2011 - May 2014)
Senior International Payer Strategy Leader @ (January 2008 - June 2011)
Global Pricing and Market Access Director @ (February 2002 - September 2007)
Outcomes Research Manager @ (January 2000 - November 2002)
Health Outcomes Executive @ (January 1998 - January 2000)
Medical Communications Manager @ (January 1996 - January 1998)
Emma Carr Education
University of Cambridge
PhD (Pharmacology)
University of Ulster
BSc Hons (Biomedical Sciences)
City University (GB)
MSc (Health Economics)
Emma Carr Skills
HTA
Market Access
Outcomes Research
Health Economics
Pharmaceutical Industry
Medical Devices
Sales Effectiveness
Strategy
Regulatory Affairs
Cardiology
Clinical Trials
Lifesciences
Pharmacoeconomics
Clinical Research
Medical Affairs
Therapeutic Areas
Clinical Development
Diabetes
Drug Development
Global Marketing
Medical Writing
Medical Communications
Pricing
CRO
Biotechnology
Pharmacovigilance
Oncology
Epidemiology
Biopharmaceuticals
Hematology
Pharmaceutics
Infectious Diseases
Drug Discovery
Neurology
Vaccines
Pharmaceutical Sales
Life Sciences
Policy
Customer Service
Project Management
Emma Carr Summary
Emma Carr, based in Dublin, IE, is currently a Director of Market Access at Novo Nordisk. Emma Carr brings experience from previous roles at Amryt Pharma plc, Sobi - Swedish Orphan Biovitrum AB (publ), Roche and Amgen (Europe GmbH). Emma Carr holds a PhD in Pharmacology @ University of Cambridge. With a robust skill set that includes HTA, Market Access, Outcomes Research, Health Economics, Pharmaceutical Industry and more. Emma Carr has 3 mobile phone numbers on RocketReach.
Looking for a different Emma Carr?
Find contact details for 700 million professionals.